EUVIMEDEUVIMED entdecken
Leitlinie

Disparities in Timeliness and Guideline‐Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer Patients

Jonathan Pham, Tiffany Lin, Eldho Paul, Margaret Brand, Sanuki Tissera, Matthew Conron, Gavin Wright, Michelle Caldecott, Gary Richardson, Phillip Antippa, Wasek Faisal, Susan Harden und 2 weitere

Asia-Pacific Journal of Clinical Oncology · 2026

DOI: 10.1111/ajco.14219 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2026. Verfasst von Jonathan Pham und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms, Hospitals, Public, Hospitals, Private, Healthcare Disparities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous literature has highlighted health inequality in lung cancer treatment, possibly related to differential healthcare delivery across public and private hospitals. In this study we assessed the association between public and private hospital receipt of guideline‐concordant treatment (GCT) and survival.

Methods

A retrospective study of patients in the Victorian Lung Cancer Registry was performed between April 2011 and March 2022. Models were adjusted for propensity score (age, sex, performance status, histology, ethnicity, smoking, hospital location, socioeconomic status, comorbidities, comorbid cancer). Main outcome measures were timeliness of treatment, receipt of GCT, and survival between private and public hospital‐admitted patients.

Findings

Of 11,396 patients, 9213 (81%) patients had treatment in public hospitals. Compared to private‐hospital patients, public‐hospital patients experienced substantial treatment delay (median referral‐to‐treatment interval: 48 vs. 29 days, p < 0.001). After adjusting for propensity score, private‐hospital patients were more likely to receive GCT in all stages of non‐small‐cell lung cancer (NSCLC) except stage III (Stage I: OR 2.77, p < 0.001; Stage II: OR 3.43, p < 0.001; Stage III: 1.06, p = 0.73; Stage IV: OR 2.14, p < 0.001). The private‐hospital patients had lower risk of death in NSCLC stages I, II and IV and a near‐significant benefit in stage III (Stage I: OR 0.67, p < 0.001; Stage II: OR 0.54, p < 0.001; Stage III: 10.81, p = 0.06; Stage IV: OR 0.79, p < 0.001).

Interpretation

Compared to private, the public‐hospital patients experienced substantial delay in lung‐cancer treatment, lower standard of GCT, and poorer survival rate. This study highlights substantial health inequity and disparity, demanding a need to evaluate, assess, and improve lung cancer treatment in Australian hospitals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHospitals, PublicHospitals, PrivateHealthcare DisparitiesGuideline AdherenceCarcinoma, Non-Small-Cell LungHumansMaleFemaleRetrospective StudiesAgedMiddle AgedPractice Guidelines as Topic

Stichwörter der Autor:innen

lung cancermortalityprivate healthpublic healthtreatment

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
  • School of Public Health and Preventive Medicine, Monash University, and Department of Medical Oncology, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Respiratory Medicine, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Department of Cardiothoracic Surgery and Department of Surgery, University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
  • Epworth Healthcare, Richmond, Victoria, Australia.

Zitieren

APA

Pham, J., Lin, T., Paul, E., Brand, M., Tissera, S., Conron, M., Wright, G., Caldecott, M., Richardson, G., Antippa, P., Faisal, W., Harden, S., Zalcberg, J., & Stirling, R. G. (2026). Disparities in Timeliness and Guideline‐Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer Patients. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14219

Vancouver

Pham J, Lin T, Paul E, Brand M, Tissera S, Conron M, et al. Disparities in Timeliness and Guideline‐Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer Patients. Asia-Pacific Journal of Clinical Oncology. 2026. doi:10.1111/ajco.14219

BibTeX
@article{Pham2026,
  author = {Pham, Jonathan and Lin, Tiffany and Paul, Eldho and Brand, Margaret and Tissera, Sanuki and Conron, Matthew and Wright, Gavin and Caldecott, Michelle and Richardson, Gary and Antippa, Phillip and Faisal, Wasek and Harden, Susan and Zalcberg, John and Stirling, Robert G},
  title = {Disparities in Timeliness and Guideline‐Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer Patients},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1111/ajco.14219}
}
Kostenlos starten →